[Chordoid gliomas of the third ventricle].
A N KonovalovI V ChernovMarina RyzhovaD I PitskhelauriYu V KushelL I AstafievaOleg SharipovI S KlochkovaYu G SidnevaG P SnigirevaP L KalininPublished in: Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko (2023)
Chordoid glioma is a benign tumor predominantly localized in the third ventricle. Preoperative MRI and CT in some cases make it possible to suspect chordoid glioma and differentiate this tumor from craniopharyngioma, meningioma and pituitary adenoma by such signs as isointense signal in T1WI, hyper- or isointense signal in T2WI, homogeneous contrast enhancement and edema of basal ganglia in T2 FLAIR images. The only effective treatment for chordoid glioma is surgery. Total resection is often impossible or extremely dangerous due to location of tumor, large size and invasion of the third ventricle. Postoperative mental disorders and diabetes insipidus, including severe hypernatremia, are common that requires mandatory monitoring of water and electrolyte balance.
Keyphrases
- pulmonary artery
- contrast enhanced
- pulmonary hypertension
- mitral valve
- type diabetes
- patients undergoing
- magnetic resonance imaging
- computed tomography
- magnetic resonance
- cardiovascular disease
- minimally invasive
- deep learning
- coronary artery
- heart failure
- early onset
- coronary artery bypass
- ionic liquid
- congenital heart disease
- coronary artery disease
- optical coherence tomography
- metabolic syndrome
- convolutional neural network
- pulmonary arterial hypertension
- acute coronary syndrome
- cell migration
- left ventricular
- image quality
- dual energy
- skeletal muscle
- combination therapy
- positron emission tomography
- atrial fibrillation
- african american
- weight loss
- surgical site infection